Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine
R. Menezes Martinsa,1, A.R.S. Périsséb, L.A.B. Camachob, M.L. Lealc, M.L.S. Maiaa, A. Hommad, E. Jessourounc,
Corresponding author
ellen@bio.fiocruz.br

Corresponding author.
a Clinical Advisory Unit, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
b National School of Public Health, Fiocruz, Rio de Janeiro, RJ, Brazil
c Bacterial Technology Laboratory, Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
d Bio-Manguinhos/Fiocruz, Rio de Janeiro, RJ, Brazil
Read
275
Times
was read the article
112
Total PDF
127
Total HTML
36
Total EPUB
Share statistics
Article information
ISSN: 14138670
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2022 January 41 26 9 76
2021 December 70 69 22 161
2021 November 16 17 5 38

Follow this link to access the full text of the article

The Brazilian Journal of Infectious Diseases

Subscribe to our newsletter